Oligonucleotides project applies machine learning to advance characterisation and smart manufacturing

Intellegens and CPI, in collaboration with industry partners, are applying machine learning to meet the challenges of characterisation and manufacturing in the emerging field of oligonucleotide therapies. Find out more about the project and its progress through the following resources.

Project news

Press release – Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning

Events

5 Mar, 2024 – Intellegens will attend the 11th Annual Oligonucleotides Networking event at GSK, Stevenage. Contact us to arrange to meet at the event.

26 Mar, 2024 – Webinar: Machine learning for smart manufacturing: oligonucleotide case study

More information

Intellegens solutions for life sciences

White paper – Five ways machine learning can power life science data analysis